3247. A phase II study of osimertinib in patients with NSCLC harboring EGFR exon 20 insertion: A multicenter trial of the Korean Cancer Study Group (LU17-19)
Yu Jung Kim 1, Soyeon Kim 2, Tae Min Kim 3, Koung Jin Suh 1, Miso Kim 4, Se Hyun Kim 1, Bhumsuk Keam 4, Dong-Wan Kim 4, Jong Seok Lee 1, Dae Seog Heo 4
3246. Risk factors for resistant gram-positive bacteremia in febrile neutropenic patients with cancer
Minkyeong Lee, Chan Mi Lee, Ja Min Byun, Dong-Yeop Shin, Youngil Koh, Junshik Hong, Pyoeng Gyun Choe, Wan Beom Park, Nam Joong Kim, Sung-Soo Yoon, Myoung-Don Oh, Chang Kyung Kang, Inho Kim
3245. Genetic Risk Factors for Bortezomib-induced Neuropathic Pain in an Asian Population: A Genome-wide Association Study in South Korea
Young Gi Min, Sung-Yeoun Lee, Ehyun Lim, Mi-Young Park, Dong-Ho Kim, Ja Min Byun, Youngil Koh, Junshik Hong, Dong-Yeop Shin, Sung-Soo Yoon, Jung-Joon Sung, Seog Bae Oh, Inho Kim
3243. Clinicomicrobiological risk factors for infective endocarditis in
viridans group streptococci bacteraemia
Jiyeon Bae, Jae Hyeon Park, Minkyeong Lee, Hyeon Jae Jo, Chan Mi Lee, Chang Kyung Kang, Pyoeng Gyun Choe, Wan Beom Park, Nam Joong Kim, Inho Kim, Myoung-Don Oh
3239. Combination of local radiotherapy and anti-glucocorticoid-induced tumor
necrosis factor receptor (GITR) therapy augments PD-L1 blockade-mediated
anti-tumor effects in murine breast cancer model
Jun Yeong Song, Min Guk Han, Yoomin Kim, Min Ji Kim, Mi Hyun Kang, Seung Hyuck Jeon, In Ah Kim